Literature DB >> 24118525

Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.

C C Naidoo1, M Pillay.   

Abstract

The role of fitness in transmission of drug-resistant strains has been explored in previous studies; but has not been established for F15/LAM4/KZN strains, which were responsible for the extensively drug-resistant tuberculosis (XDR-TB) outbreak in Tugela Ferry, South Africa. The biological fitness of 15 clinical strains representing the F15/LAM4/KZN, Beijing, F11 and F28 families was determined by growth, viability and competition assays and correlated with DNA sequencing of eight genes associated with drug resistance and putative compensatory mechanisms. Similar growth rates were observed among susceptible, multidrug-resistant (MDR) and XDR strains of the KZN and F28 genotypes. In contrast, Beijing and F11 MDR strains demonstrated significantly reduced fitness. Resistant strains exhibited heterogeneous fitness profiles in competition with different susceptible strains, suggesting strain dependence. In addition, co-culture growth rates were consistently higher than independent growth rates in 13/14 competition pairs. All 14 drug-resistant strains retained viability, at a low CFU/mL, when paired with susceptible strains. The persistence of such resistant strains could consequently support the acquisition of additional drug-resistance-conferring mutations and/or the evolution of compensatory mechanisms. Frequently occurring mutations were detected in KZN and F28 resistant strains whereas, the Beijing MDR strain harboured a less common katG mutation and the F11 MDR strain had no katG mutation. Contrary to drug-resistant Beijing and F11 strains, the successful transmission of KZN strains, particularly during the outbreak, may be attributed to the presence of drug-resistance-conferring mutations associated with little or no associated fitness costs. Amplified growth in co-culture may be suggestive of in vivo trans-complementation.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Competition; F15/LAM4/KZN; Mycobacterium tuberculosis; extensively drug-resistant; fitness; growth; multidrug-resistant; mutation

Mesh:

Year:  2013        PMID: 24118525     DOI: 10.1111/1469-0691.12415

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

1.  Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand.

Authors:  Sanjib Mani Regmi; Angkana Chaiprasert; Supasak Kulawonganunchai; Sissades Tongsima; Olabisi Oluwabukola Coker; Therdsak Prammananan; Wasna Viratyosin; Iyarit Thaipisuttikul
Journal:  Mol Genet Genomics       Date:  2015-04-24       Impact factor: 3.291

2.  Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.

Authors:  Charissa C Naidoo; Manormoney Pillay
Journal:  J Genet       Date:  2017-09       Impact factor: 1.166

3.  Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.

Authors:  Amber Kunkel; Frank G Cobelens; Ted Cohen
Journal:  PLoS Med       Date:  2016-10-11       Impact factor: 11.069

4.  Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.

Authors:  Navisha Dookie; A Willem Sturm; Prashini Moodley
Journal:  BMC Infect Dis       Date:  2016-10-26       Impact factor: 3.090

5.  Competitive fitness of Mycobacterium tuberculosis in vitro.

Authors:  Ousmane Kodio; Antieme Combo Georges Togo; Yeya Dit Sadio Sarro; Bintou Fane; Fatimata Diallo; Amadou Somboro; Boureima Degoga; Mahamadou Kone; Gagni Coulibaly; Mohamed Tolofoudje; Sidy Bane; Moumine Sanogo; Bourahima Kone; Nadie Coulibaly; Djeneba Dabitao; Bocar Baya; Mamoudou Maiga; Flabou Bougoudogo; Fasse Samake; Sounkalo Dao; Seydou Doumbia; Souleymane Diallo; Bassirou Diarra
Journal:  Int J Mycobacteriol       Date:  2019 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.